NewInsight: Anthropic's IPO price against 48 tech IPOs since 1997

Apnimed APMD

Apnimed listed on Nasdaq on 31 Jul 2026 and is not in the S&P 500. It is worth $718 million. Its price history starts on 31 Jul 2026. 7 directors have filed with the SEC in the last 12 months (who counts), 1 of them an executive. 2 other officers are on file.

CEO
Kevin Robert Lind
Listed
31 Jul 2026 on Nasdaq, IPO filings and terms
Headquarters
Cambridge, MA
Market cap
$718M
19 Nov 2026 close
Revenue
-
No annual report yet

Financials

Financial history

Twelve months to 30 Sep 2026, from Apnimed's quarterly filings.

Quarters since Jun 2025

P/E
-
No profit over the last four quarters

Quarterly results

Each quarter's revenue, net income and free cash flow.

Jun 2025 to Sep 2026

$0$5M$10M$15M$20M20252026$2M

Apnimed's market cap since July 2026

Weekly, up to 13 Nov 2026

Aug 2026SepOctNov$700M

Board and leadership

Board and officers

1 person here also holds roles at other S&P 500 companies.

Roles filed up to 30 Sep 2026

NameTitle
Directors (7)
Kevin Robert LindChief Executive OfficerChief Executive Officer
Chris DimitropoulosDirectorDirector
Paul R. FonteyneDirectorDirector
William A. Jones Jr.DirectorDirector
Lawrence G. MillerDirectorDirector
Paul J. SekhriDirectorAlso at Veeva SystemsDirector
Gary SenderDirectorDirector
Officers (2)
Michael B. KellyChief Financial OfficerLast filed 3 Aug 2026Chief Financial Officer
Dennis Patrick MolnarPresidentLast filed 3 Aug 2026President

Owners and trading

Insider trades

Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.

Trades from 19 Nov 2025 to 19 Nov 2026

Directors and officers made no open-market sales and bought $200,000 in 1 purchase in the 12 months to 19 Nov 2026.

DatePersonTitleTypeSharesValue
3 Aug 2026BuyPaul J. SekhriDirectorDirectorBuy12,500$200K

Not on file: no trades disclosed by members of Congress or officials since November 2023, no WARN layoff notices under its own name or a listed subsidiary's since November 2023, no open roles from its careers site yet, no earnings release figures from the last six months and no director or officer changes, WARN notices or large insider sales in the last two years. 13F holdings: Apnimed listed after the last quarter (30 Jun 2026). The next 13F filings were due by 14 Nov 2026.